GC Rieber VivoMega Introduces High-Concentration 90% TG Premium Fish Oil

Norwegian omega-3 concentrate producer GC Rieber VivoMega has announced the launch of VivoMega 90% TG Premium fish oil.¹ The ingredient, designed for advanced supplement formulations, represents an increase in potency for the company's product portfolio.

The new ingredient was officially introduced to the industry at this year’s Vitafoods Europe exhibition in Barcelona. “Our new 90% ingredient was well received at the show, we had a lot of interest from brands interested in expanding their portfolio into super high omega-3 concentrates,” stated Ståle Søfting, Chief Commercial Officer at GC Reiber VivoMega.²

Technical Specifications and Formulation Benefits

The newly developed VivoMega 90% TG Premium fish oil delivers an increased concentration of omega-3 fatty acids, providing 520 mg of EPA and 310 mg of DHA per gram. This yields a total omega-3 content of 900 mg/g, or 90% total concentration. The ingredient is manufactured in a natural triglyceride (TG) form, which is utilized to support bioavailability and absorption for the end consumer.

For finished product manufacturers, this high-potency profile offers significant formulation flexibility. The concentration allows supplement brands to develop high-strength products while simultaneously reducing overall capsule size, the company notes. According to Søfting, the ingredient addresses a specific market demand from brands seeking to deliver higher potency products without compromising the user experience, allowing for smaller, easier-to-swallow capsules without sacrificing sensory profiles. “The super high segment continues to attract interest as a way to differentiate in a saturated marketplace,” he explained. “We also see continued growth in algae-based omega-3 solutions, driven by vegetarian and vegan consumer demand, interest in plant-based nutrition, and increasing consumer awareness around the importance of EPA and DHA specifically. As awareness grows, consumers are becoming more focused on the omega-3 content and health benefits rather than whether the source is fish- or algae-based.”

The oil is designed for integration into a wide variety of applications, including softgels, standard capsules, and other functional formats.

Quality Standards and Manufacturing Sustainability

The 90% TG Premium fish oil is produced to align with international quality and purity benchmarks. GC Rieber VivoMega reports that the ingredient meets and exceeds the industry-leading oxidation parameters and environmental specifications established by organizations such as the Global Organization for EPA and DHA Omega-3s (GOED) and the International Fish Oil Standards (IFOS). These standards are intended to ensure batch-to-batch stability, safety, and consistency for manufacturers.

In addition to purity metrics, the manufacturing process incorporates specific sustainability frameworks. GC Rieber VivoMega operates production facilities that align with the European Union’s Green Deal initiatives as well as the United Nations Global Compact guidelines. Furthermore, the company holds SEDEX certification, reflecting its supply chain and traceability practices.

“When ensuring a traceable and sustainable supply chain, key challenges include raw material transparency, supply stability, and credible certification,” explained Merethe Thomassen, communications and marketing manager at GC Rieber VivoMega in a previous interview with Nutritional Outlook.³ “GC Rieber VivoMega addresses these through close supplier collaboration, third-party verification, and continuous improvement of traceability systems. We see sustainability as a shared responsibility across the value chain, ensuring that every product we deliver meets high environmental, ethical, and quality standards our customers can trust.”

Additional Product Launches

The launch follows previous infrastructure expansions at the company's Norwegian operations, which included the addition of a specialized, high-concentration production facility capable of scaling up to the 900 mg/g DHA and EPA outputs, alongside their vegan Algae EPA and DHA options.

In February, the company introduced its new high-potency vegan omega-3 ingredient, Algae 1045 TG.⁴ The new ingredient, a combination of DHA and EPA in triglyceride form, was designed to preserve bioavailability and purity, and to support multiple applications. It is produced using the GC Rieber VivoMega’s proprietary SuperLight processing technology, designed to enhance oxidation protection, safeguard molecular integrity, and optimize overall resource utilization, all of which support minimal to zero-waste outcomes, the company explained.

This article was created with assistance from AI. The content has been reviewed and edited by Erin McEvoy, Associate Editor. For more information on the extent and nature of AI usage, please contact us.

References

1. GC Rieber VivoMega. GC Rieber VivoMega Launches 90% High-Concentration Fish Oil for Advanced Omega-3 Formulations. April 14, 2026. Accessed May 18, 2026. Press release provided via email.
2. Søfting S. Commentary provided to Nutritional Outlook via email. May 18, 2026.
3. McEvoy E. GC Rieber VivoMega expands omega-3 portfolio with launch of vegan DHA and EPA algal oil. February 18, 2026. Accessed May 18, 2026. https://www.nutritionaloutlook.com/view/gc-rieber-vivomega-expands-omega-3-portfolio-with-launch-of-vegan-dha-and-epa-algal-oil
4. McEvoy E. How GC Rieber VivoMega is adapting fish and algal omega-3 production to a changing market. January 27, 2026. Accessed May 18, 2026. https://www.nutritionaloutlook.com/view/how-gc-rieber-vivomega-is-adapting-fish-and-algal-omega-3-production-to-a-changing-market